Mesalazine is an aminosalicylate anti-inflammatory medication primarily used to treat inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease, by modulating immune responses and inhibiting… Read more



![Chemical structure of 1-(3-Carboxy-4-hydroxyphenyl)-6-hydroxy-1H-benzo[d]imidazole-7-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F147396-04-1-1-3-Carboxy-4-hydroxyphenyl-6-hydroxy-1H-benzodimidazole-7-carboxylic-Acid.png&w=3840&q=75)









![Chemical structure of 2-Hydroxy-5-nitro-4'-sulfo-[1,1'-biphenyl]-3-carboxylic acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-Hydroxy-5-nitro-4-sulfo-11-biphenyl-3-carboxylic-acid.png&w=3840&q=75)













![Chemical structure of 5-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]-2-hydroxybenzoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F876903-48-9-5-2-Formyl-5-hydroxymethyl-1H-pyrrol-1-yl-2-hydroxybenzoic-Acid.png&w=3840&q=75)






















Mesalazine is an aminosalicylate anti-inflammatory medication primarily used to treat inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease, by modulating immune responses and inhibiting inflammatory mediators within the gastrointestinal tract. To maintain rigorous quality control and ensure regulatory compliance, pharmaceutical laboratories utilize highly precise reference standards for mesalazine, including its pharmacopeial and non-pharmacopeial impurities. Impurity profiling of these synthetic byproducts and degradation products is essential for validating analytical methods and confirming the safety of the final drug product. Furthermore, stable isotope labelled compounds are indispensable in advanced analytical workflows, functioning as internal standards for the accurate quantification of mesalazine and its metabolites in complex biological matrices via mass spectrometry. This collection provides the necessary materials to support consistent analytical performance, method development, and pharmacokinetic research throughout the pharmaceutical manufacturing and testing lifecycle.